Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

916 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].
Grupo de expertos del Grupo de Estudio sobre Alteraciones Metabólicas (GEAM), de la Secretaría del Plan Nacional sobre el Sida (SPNS) y del Grupo de Estudio de Sida (GeSIDA); Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E. Grupo de expertos del Grupo de Estudio sobre Alteraciones Metabólicas (GEAM), de la Secretaría del Plan Nacional sobre el Sida (SPNS) y del Grupo de Estudio de Sida (GeSIDA), et al. Among authors: ortega e. Enferm Infecc Microbiol Clin. 2015 Jan;33(1):40.e1-40.e16. doi: 10.1016/j.eimc.2014.06.006. Epub 2014 Aug 28. Enferm Infecc Microbiol Clin. 2015. PMID: 25176009 Spanish.
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA); Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, Von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E. Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA), et al. Among authors: ortega e. Enferm Infecc Microbiol Clin. 2015 Jan;33(1):41-7. doi: 10.1016/j.eimc.2014.05.018. Epub 2014 Aug 3. Enferm Infecc Microbiol Clin. 2015. PMID: 25096166
[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].
Polo R, José Galindo M, Martínez E, Alvarez J, Arévalo JM, Asensi V, Cánoves D, Cáncer E, Collazos J, Estrada V, Gómez-Candela C, Johnston S, Locutura J, López-Aldeguer J, Lozano F, Miralles C, Muñoz-Sanz A, Ortega E, Pascua J, Pedrol E, Pulido F, San Martín M, Sanz J, Viciana P, Chamorro L; Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS). Polo R, et al. Among authors: ortega e. Enferm Infecc Microbiol Clin. 2006 Feb;24(2):96-117. doi: 10.1157/13085017. Enferm Infecc Microbiol Clin. 2006. PMID: 16545318 Spanish.
Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
Panel of experts from the National AIDS Plan (PNS); AIDS Study Group (GeSIDA); Spanish Society of Occupational Health Safety at Work (SEMST); Spanish Society of Preventive Medicine Public Health Hygiene (SEMPSPH); Spanish Association of Specialists in Occupational Medicine (AEEMT); Spanish Society of Occupational Health in Public Administration (SESLAP); National Association of Occupational Medicine in Health (ANMTAS); Spanish Society of Paediatric Infectology (SEIP); Spanish Society for Emergency Medicine (SEMES); Study Group for Viral Hepatitis-SEIMC (GEHEP); Spanish Federation of Occupational Health Nursing (FEDEET); Polo Rodriguez R, Lozano F, González de Castro P, Jiménez MA, Miró O, Ramón Blanco J, Moreno D, Dueñas C, Muñoz Platón E, Fernández Escribano M, Sanz Sanz J, Fumaz C, Santos I, García F, Téllez MJ, González Montero R, Vals Jimenez MV, Losa J, Valle Robles ML, Iribarren J, Ortega E. Panel of experts from the National AIDS Plan (PNS), et al. Among authors: ortega e. Enferm Infecc Microbiol Clin. 2016 Feb;34(2):122-31. doi: 10.1016/j.eimc.2015.08.004. Epub 2015 Oct 23. Enferm Infecc Microbiol Clin. 2016. PMID: 26474709
[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy].
Llibre JM, Antela A, Arribas JR, Domingo P, Gatell JM, López-Aldeguer J, Lozano F, Miralles C, Moltó J, Moreno S, Ortega E, Riera M, Rivero A, Villalonga C, Clotet B. Llibre JM, et al. Among authors: ortega e. Enferm Infecc Microbiol Clin. 2010 Nov;28(9):615-20. doi: 10.1016/j.eimc.2010.08.004. Enferm Infecc Microbiol Clin. 2010. PMID: 20888082 Review. Spanish.
Clinical utility of maraviroc.
Parra J, Portilla J, Pulido F, Sánchez-de la Rosa R, Alonso-Villaverde C, Berenguer J, Blanco JL, Domingo P, Dronda F, Galera C, Gutiérrez F, Kindelán JM, Knobel H, Leal M, López-Aldeguer J, Mariño A, Miralles C, Moltó J, Ortega E, Oteo JA. Parra J, et al. Among authors: ortega e. Clin Drug Investig. 2011;31(8):527-542. doi: 10.2165/11590700-000000000-00000. Clin Drug Investig. 2011. PMID: 21595497 Review.
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
Podzamczer D, Olmo M, Sanz J, Boix V, Negredo E, Knobel H, Domingo P, Pineda JA, Vilades C, Quero JH, Force L, Lahoz JG, Muñoz P, Llibre JM, Mariño A, Ortega E, Dalmau D, Gatell JM, Antón E, Sola J, Galindo MJ, Pedrol E, Sanz J, Lima JT, Flores J; NODy Study Group. Podzamczer D, et al. Among authors: ortega e. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):390-6. doi: 10.1097/QAI.0b013e318198a0cc. J Acquir Immune Defic Syndr. 2009. PMID: 19214120 Clinical Trial.
Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain.
Gutiérrez F, Padilla S, Masiá M, Flores J, Boix V, Merino E, Galindo J, Ortega E, López-Aldeguer J, Galera C; HIV-related Osteonecrosis Study Group. Gutiérrez F, et al. Among authors: ortega e. J Acquir Immune Defic Syndr. 2006 Jul;42(3):286-92. doi: 10.1097/01.qai.0000225012.53568.20. J Acquir Immune Defic Syndr. 2006. PMID: 16763523
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group. Berenguer J, et al. Among authors: ortega e. J Hepatol. 2013 Jun;58(6):1104-12. doi: 10.1016/j.jhep.2013.01.042. Epub 2013 Feb 7. J Hepatol. 2013. PMID: 23395690
Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.
Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, Wire MB. Pérez-Elías MJ, et al. Among authors: ortega e. Antimicrob Agents Chemother. 2009 Dec;53(12):5185-96. doi: 10.1128/AAC.00632-09. Epub 2009 Aug 10. Antimicrob Agents Chemother. 2009. PMID: 19667283 Free PMC article. Clinical Trial.
916 results